Loading clinical trials...
Loading clinical trials...
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of HCV Recurrence and Progression Post Liver Transplantation
Conditions
Locations
1
Canada
Toronto General Hospital (University Health Network)
Toronto, Ontario, Canada
Start Date
June 1, 2008
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
July 25, 2013
NCT06953479
NCT07233096
NCT06717919
NCT03135886
NCT05968573
NCT06899867
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions